Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib Maintenance in Hormone Refractory Prostate Cancer
NCT00550810Phase 2Unknown
- Sponsor
- Alberta Health Services
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in castration-resistant prostate cancer (CRPC), sponsored by Alberta Health Services. Status: unknown.
02
Drugs
sunitinib
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT00550810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550810.